Nebulisers convert liquids into a cloud of droplets suitable for respiration. Conventional nebulisers are widely used in both hospital and home. Their main advantage is that unlike other devices, they require little or no coordination on the part of the patient in order to use them.
In 2006, the European Medicines Agency (EMA) issued a new “Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products” in which they included regulatory guidance on the drug aspects of nebulisers on the grounds that the safety and efficacy of nebulisers are dependent on the nebuliser/drug combination and not just on the nebuliser alone.
As results published in 2004 indicated, the NGI could be used to meet the requirements of the future standard using a system as indicated below.
Please select an impactor:
22nd August 2016; Nottingham, UK: Copley Scientific, the world’s leading manufacturer and suppl...Find Out More
24 July 2007; Nottingham, UK: The accuracy of cascade impactors used in the pharmaceutical indust...Find Out More
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Coronavirus – The latest update from Copley Scientific –